Učitavanje...
Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers
Hematopoietic stem cell transplantation has been used for more than 50 years to combat hematologic malignancies. In addition to being the first stem cell therapy, transplantation has provided evidence for the potent anti-tumor effects of T cells. Facilitating T-cell-based immunity against malignanci...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3874121/ https://ncbi.nlm.nih.gov/pubmed/24329800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12142 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|